ConductScience.org, home

Cell line · CVCL_0036

RT-4

Cancer cell line, Homo sapiens. Bladder carcinoma. 79 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. RT-4. Cell lines, record CVCL_0036. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0036

On this page

Cell line

As Cellosaurus gives it.

Name
RT-4
Accession
CVCL_0036
RRID
RRID:CVCL_0036
Synonyms
RT4, RT4P
Species
Homo sapiens (Human)
Sex
Male
Age at sampling
63Y
Category
Cancer cell line
Diseases
Bladder carcinoma (NCIt C4912)
Derived from
Urinary bladder (in situ)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers79

1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.

PaperJournalYearHow we knowRetractedSource
An MMP-14/STAT3 feedback loop upregulates PD-L1 to drive immunosuppression and tumorigenesis in bladder cancer.iScience2026Its Methods give the RRID and name the linePubMed
SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis.Transl Androl Urol2026Its Methods give the RRID and name the linePubMed
Reprogramming-driven Proteomic Shifts Mirror Bladder Cancer Progression and Reveal Biomarker Candidates Across Disease Grades.Cancer Genomics Proteomics2026Its Methods give the RRID and name the linePubMed
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture.Cancer Discov2026Its Methods give the RRID and name the linePubMed
The Antipsychotic Aripiprazole Induces Cytotoxicity in Bladder Cancer Cells While Preserving Urothelial and Bladder Function.Pharmacol Res Perspect2026Its Methods give the RRID and name the linePubMed
O-GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
The bladder cancer m6A landscape is defined by global methylation dilution and focal 3'-UTR hypermethylation.EMBO Rep2026Its Methods give the RRID and name the linePubMed
SREBP2-RAB11A-ZDHHC20 axis orchestrates FGFR3 palmitoylation and membrane retention to drive bladder cancer progression.Cell Oncol (Dordr)2026Its Methods give the RRID and name the linePubMed
Mechanisms of Aristolochic Acid Resistance in Specialist Butterflies and Evolutionary Insights for Potential Protective Pathways.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Crucial Contribution of BACH1 to Bladder Cancer Progression via Upregulating Epithelial-Mesenchymal Transition Pathway.Cancer Sci2026Its Methods give the RRID and name the linePubMed

1 to 10 of 79

See all 79 papers

Relatives7

RelationCell lineAccessionProblemSource
Derived from itEDITGENE PTGER4 Knockout RT4 Cell LineCVCL_F5BXCell lines
Derived from itEDITGENE RT4-CopGFPCVCL_F6CNCell lines
Derived from itEDITGENE RT4-FLUCCVCL_F5VNCell lines
Derived from itRT4/31CVCL_2715Cell lines
Derived from itRT4rCDDP1000CVCL_RR19Cell lines
Derived from itRT4rGEMCI10CVCL_RR20Cell lines
Derived from itRT4v6CVCL_T027Cell lines

Cell banks10

Cell bankCatalog numberStatusSource
ATCCCRL-7937DiscontinuedCellosaurus
ATCCHTB-2ATCC
BCRC60111BCRC
BCRJ0214BCRJ
CLS300326CLS
DSMZACC-412DSMZ
ECACC91091914ECACC
EDITGENEEDC00335EDITGENE
KCBKCB 2016045YJCellosaurus
KCLB30002KCLB

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0036

GET https://conductscience.org/api/cell-lines/v1/CVCL_0036/papers?page=2